|
|
||||||||
1 Department of Developmental Biology and Anatomy, University of South Carolina School of Medicine, Columbia 29208; 2 Department of Chemistry, University of South Carolina, Aiken, South Carolina 29801; 3 Division of Molecular Cardiovascular Biology, The Children's Hospital and Research Foundation, Cincinnati, Ohio 45229-3039; 4 Cardiovascular Division, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts 02215; and 5 Department of Biological Sciences, University of Auckland, Auckland, New Zealand 1020
Integrin-mediated cell-extracellular
matrix (ECM) interactions are essential for multiple cellular
processes; however, little is known regarding integrin turnover during
these events. Recent studies have demonstrated shedding of cell surface
molecules and suggested this as a potential mechanism for integrin
turnover. Confocal microscopy of mouse hearts under different
physiological conditions demonstrated the presence of
1-integrin-immunoreactive material in the interstitium.
Culture media from neonatal rat cardiac myocytes and fibroblasts
contained a 55-kDa fragment of
1-integrin. Attachment to
ECM components, response to phorbol 12-myristate 13-acetate
stimulation, and matrix metalloproteinase inhibition assays
demonstrated that fibroblasts responded differently to the fragment
compared with myocytes. The
1-integrin fragment stimulated myocyte attachment to collagen and the fragment itself bound
a variety of ECM proteins. These studies indicate that as myocytes and
fibroblasts change size and shape, cellular contacts with the ECM are
altered, resulting in the liberation of a
1-integrin fragment from the cell surface. Integrin shedding may represent a novel
mechanism of rapidly modifying cell-ECM contacts during various
cellular processes.
integrins; hypertrophy; extracellular matrix; metalloproteinases
This article has been cited by other articles:
![]() |
F. G. Spinale Myocardial Matrix Remodeling and the Matrix Metalloproteinases: Influence on Cardiac Form and Function Physiol Rev, October 1, 2007; 87(4): 1285 - 1342. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Krishnamurthy, V. Subramanian, M. Singh, and K. Singh {beta}1 Integrins Modulate {beta}-Adrenergic Receptor-Stimulated Cardiac Myocyte Apoptosis and Myocardial Remodeling Hypertension, April 1, 2007; 49(4): 865 - 872. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Manso, L. Elsherif, S.-M. Kang, and R. S. Ross Integrins, membrane-type matrix metalloproteinases and ADAMs: Potential implications for cardiac remodeling Cardiovasc Res, February 15, 2006; 69(3): 574 - 584. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Menon, M. Singh, and K. Singh Matrix metalloproteinases mediate {beta}-adrenergic receptor-stimulated apoptosis in adult rat ventricular myocytes Am J Physiol Cell Physiol, July 1, 2005; 289(1): C168 - C176. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. E. Gardiner, J. F. Arthur, M. L. Kahn, M. C. Berndt, and R. K. Andrews Regulation of platelet membrane levels of glycoprotein VI by a platelet-derived metalloproteinase Blood, December 1, 2004; 104(12): 3611 - 3617. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |